- US-listed companies
- Merck & Co., Inc.
- Cash flow
Merck & Co., Inc.MRK
Market cap
$251.9B
P/E ratio
| 2010/12 | 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Depreciation & amortization | 7,381 | 7,427 | 6,978 | 6,988 | 6,691 | 6,375 | 5,441 | 4,637 | 4,519 | 3,652 | - | - | - | - | - |
| Stock-based compensation | 509 | 369 | 335 | 276 | 278 | 299 | 300 | 312 | 348 | 417 | 475 | 479 | 541 | 645 | 761 |
| Cash from operations | 10,822 | 12,383 | 10,022 | 11,654 | 7,860 | 12,421 | 10,376 | 6,447 | 10,922 | 13,440 | 10,253 | 13,122 | 19,095 | 13,006 | 21,468 |
| Capital expenditures | -1,678 | -1,723 | -1,954 | -1,548 | -1,317 | -1,283 | -1,614 | -1,888 | -2,615 | -3,473 | -4,684 | -4,448 | -4,388 | -3,863 | -3,372 |
| Cash from investing | -3,497 | -2,890 | -6,805 | -3,148 | -374 | -4,758 | -3,210 | 2,679 | 4,314 | -2,629 | -9,443 | -16,421 | -4,960 | -14,083 | -7,734 |
| Repurchases of common stock | 1,593 | 1,921 | 2,591 | 6,516 | 7,703 | 4,186 | 3,434 | 4,014 | 9,091 | 4,780 | 1,281 | 840 | - | 1,346 | 1,306 |
| Proceeds from issuance of term debt, net | 1,999 | - | 2,562 | 6,467 | 3,146 | 7,938 | 1,079 | - | - | 4,958 | 4,419 | 7,936 | - | 5,939 | - |
| Repayments of term debt | 1,341 | 1,547 | 22 | 1,775 | 6,617 | 2,906 | 2,386 | 1,103 | 4,287 | - | 1,957 | 2,319 | 2,251 | 1,755 | 1,290 |
| Cash from financing | -5,441 | -6,904 | -3,267 | -5,990 | -15,113 | -5,270 | -9,044 | -10,006 | -13,160 | -8,861 | -2,832 | 3,097 | -9,119 | -4,810 | -7,032 |
| Free cash flow | |||||||||||||||
| FCF margin (%) |